Duke U denies radiologist’s allegations of career-blocking collusion

Two years ago a Duke University radiology professor filed an antitrust lawsuit against her employer, accusing Duke of colluding with the University of North Carolina-Chapel Hill to thwart either school’s faculty members who might seek to move laterally between the two institutions. Danielle Seaman, MD, said she’d been locked out of a position she desired at UNC-CH by such an arrangement.

Last week, a former Duke dean denied the claim and asked a federal judge to can the suit. This came in the wake of a request by Seaman’s lawyers to expand the case into a class-action lawsuit alleging broader efforts to suppress wages across the medical schools.

“I am not aware of any instance in which Duke School of Medicine declined to recruit or hire anyone because he or she was a member of the [UNC-CH] faculty or staff,” Nancy Andrews, MD, PhD, dean from 2007 to 2017, wrote in a signed statement filed Oct. 23. “I am not aware of anyone at Duke who believed that he or she was prevented from hiring a medical faculty member because the candidate was from” UNC-CH.

The Durham, N.C.-based Herald Sun has the details.

For now, Duke is asking U.S. District Court Judge Catherine Eagles to reject the class-action label, the newspaper reports. “But ‘at the appropriate time,’ it also will ‘strongly dispute the existence of any agreement of the kind’ Seaman alleges.”

Click to read the article:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

HeartFlow kicked off TCT 2024 by sharing new research on the long-term impact of its FFRCT Analysis and Plaque Analysis software.

Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.

Trimed Popup
Trimed Popup